STATE STREET CORP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$44,768
-56.7%
146,7810.0%0.00%
Q2 2023$103,334
-86.2%
146,781
-82.5%
0.00%
Q1 2023$750,708
-60.7%
837,003
-48.3%
0.00%
Q4 2022$1,910,362
-68.4%
1,618,950
+101.6%
0.00%
Q3 2022$6,047,000
+36.7%
803,099
+14.3%
0.00%
Q2 2022$4,425,000
-3.8%
702,350
+26.7%
0.00%
Q1 2022$4,601,000
+62.3%
554,315
+1.5%
0.00%
Q4 2021$2,835,000
-23.6%
546,155
-1.7%
0.00%
Q3 2021$3,712,000
-19.5%
555,685
+2.6%
0.00%
Q2 2021$4,614,000
+2.1%
541,596
+6.1%
0.00%
Q1 2021$4,517,000
-26.2%
510,366
+2.5%
0.00%
Q4 2020$6,118,000
+62.5%
497,774
+7.6%
0.00%
Q3 2020$3,764,000
-14.7%
462,433
+0.6%
0.00%
Q2 2020$4,415,000
+41.3%
459,865
+0.1%
0.00%
Q1 2020$3,125,000
-52.6%
459,549
+3.8%
0.00%
Q4 2019$6,594,000
+49.2%
442,550
+2.7%
0.00%
Q3 2019$4,419,000
+16.1%
431,092
+20.1%
0.00%
Q2 2019$3,805,000
+1637.4%
358,990
+2186.7%
0.00%
Q1 2019$219,000
-42.2%
15,699
-52.5%
0.00%
Q1 2017$379,000
+6.5%
33,025
+8.3%
0.00%
Q4 2016$356,000
-0.3%
30,500
+13.8%
0.00%
Q3 2016$357,000
-16.6%
26,791
+24.3%
0.00%
Q2 2016$428,00021,5480.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders